/ Side by side
Dihexa vs Cerebrolysin
A neutral, side-by-side look at Dihexa and Cerebrolysin: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.
Dihexa
N-hexanoic-Tyr-Ile-(6) aminohexanoic amide · PNB-0408
Full profile →Cerebrolysin
FPF-1070
Full profile →| Attribute | Dihexa | Cerebrolysin |
|---|---|---|
| Category | Cognitive / Longevity | Cognitive / Longevity |
| Half-life | Not established in a public source | Not established in a public source, the product being a mixture rather than a single peptide |
| Common vial | Varies | Varies |
| Reference | Verified | Verified |
What is Dihexa?
A small-molecule angiotensin IV analog studied in preclinical models for hepatocyte growth factor / c-Met signalling and synapse formation. Preclinical only, with no registered human trials.
Sources
- PubChem compound record
- Preclinical HGF/c-Met literature
What is Cerebrolysin?
A preparation of low molecular weight peptides and amino acids derived from porcine brain tissue, studied in stroke and dementia trials and the subject of a Cochrane review. Marketed in some countries; not FDA approved.
Sources
- Cochrane Database of Systematic Reviews 2023: Cerebrolysin for acute ischaemic stroke
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.